107 related articles for article (PubMed ID: 23083548)
1. What is new in breast MRI spectroscopy.
Nelson MT; Bolan PJ; Garwood M; Everson L; Emory T; Kuehn-Hajder J
Eur J Radiol; 2012 Sep; 81 Suppl 1():S107-8. PubMed ID: 23083548
[No Abstract] [Full Text] [Related]
2. MR spectroscopy in the breast clinic is improving.
Mountford CE; Schuster C; Baltzer PA; Malycha P; Kaiser WA
Eur J Radiol; 2012 Sep; 81 Suppl 1():S104-6. PubMed ID: 23083547
[No Abstract] [Full Text] [Related]
3. CEST-imaging: A new contrast in MR-mammography by means of chemical exchange saturation transfer.
Schmitt B; Trattnig S; Schlemmer HP
Eur J Radiol; 2012 Sep; 81 Suppl 1():S144-6. PubMed ID: 23083567
[No Abstract] [Full Text] [Related]
4. L-COSY of breast cancer at 3T.
Ramadan S; Baltzer PA; Lin A; Stanwell P; Box H; Kaiser WA; Mountford CE
Eur J Radiol; 2012 Sep; 81 Suppl 1():S129-31. PubMed ID: 23083559
[No Abstract] [Full Text] [Related]
5. Quantitative multivoxel proton chemical shift imaging of the breast.
Sijens PE; Dorrius MD; Kappert P; Baron P; Pijnappel RM; Oudkerk M
Magn Reson Imaging; 2010 Apr; 28(3):314-9. PubMed ID: 20071119
[TBL] [Abstract][Full Text] [Related]
6. Hyperpolarized C-13 studies of cancer metabolism in animal models. Hype or real?
Lenkinski RE
Eur J Radiol; 2012 Sep; 81 Suppl 1():S85-6. PubMed ID: 23083616
[No Abstract] [Full Text] [Related]
7. Malignant transformation: the role of MRS.
Jiang L; Wijnen JP; Glunde K
Eur J Radiol; 2012 Sep; 81 Suppl 1():S66-8. PubMed ID: 23083608
[No Abstract] [Full Text] [Related]
8. Comparison of HR MAS MR spectroscopic profiles of breast cancer tissue with clinical parameters.
Sitter B; Lundgren S; Bathen TF; Halgunset J; Fjosne HE; Gribbestad IS
NMR Biomed; 2006 Feb; 19(1):30-40. PubMed ID: 16229059
[TBL] [Abstract][Full Text] [Related]
9. Combination of feature-reduced MR spectroscopic and MR imaging data for improved brain tumor classification.
Simonetti AW; Melssen WJ; Szabo de Edelenyi F; van Asten JJ; Heerschap A; Buydens LM
NMR Biomed; 2005 Feb; 18(1):34-43. PubMed ID: 15657908
[TBL] [Abstract][Full Text] [Related]
10. A qualitative approach to combined magnetic resonance imaging and spectroscopy in the diagnosis of prostate cancer.
Villeirs GM; Oosterlinck W; Vanherreweghe E; De Meerleer GO
Eur J Radiol; 2010 Feb; 73(2):352-6. PubMed ID: 19084363
[TBL] [Abstract][Full Text] [Related]
11. Fast nosologic imaging of the brain.
De Vos M; Laudadio T; Simonetti AW; Heerschap A; Van Huffel S
J Magn Reson; 2007 Feb; 184(2):292-301. PubMed ID: 17118683
[TBL] [Abstract][Full Text] [Related]
12. Role of apparent diffusion coefficient values for the differentiation of viable and necrotic areas of breast cancer and its potential utility to guide voxel positioning for MRS in the absence of dynamic contrast-enhanced MRI data.
Sharma U; Sah RG; Parshad R; Sharma R; Seenu V; Jagannathan NR
Magn Reson Imaging; 2012 Jun; 30(5):649-55. PubMed ID: 22459442
[TBL] [Abstract][Full Text] [Related]
13. Detection of prostate cancer with MR spectroscopic imaging: an expanded paradigm incorporating polyamines.
Shukla-Dave A; Hricak H; Moskowitz C; Ishill N; Akin O; Kuroiwa K; Spector J; Kumar M; Reuter VE; Koutcher JA; Zakian KL
Radiology; 2007 Nov; 245(2):499-506. PubMed ID: 17890357
[TBL] [Abstract][Full Text] [Related]
14. Breast magnetic resonance imaging interpretation using computer-aided detection.
Comstock C
Semin Roentgenol; 2011 Jan; 46(1):76-85. PubMed ID: 21134531
[No Abstract] [Full Text] [Related]
15. Quantification of prostate MRSI data by model-based time domain fitting and frequency domain analysis.
Pels P; Ozturk-Isik E; Swanson MG; Vanhamme L; Kurhanewicz J; Nelson SJ; Van Huffel S
NMR Biomed; 2006 Apr; 19(2):188-97. PubMed ID: 16411280
[TBL] [Abstract][Full Text] [Related]
16. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
Reinsberg SA; Payne GS; Riches SF; Ashley S; Brewster JM; Morgan VA; deSouza NM
AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance spectroscopy of the breast: current status.
Bolan PJ
Magn Reson Imaging Clin N Am; 2013 Aug; 21(3):625-39. PubMed ID: 23928249
[TBL] [Abstract][Full Text] [Related]
18. MR-spectroscopy at 1.5 tesla and 3 tesla. Useful? A systematic review and meta-analysis.
Baltzer PA; Dietzel M; Kaiser WA
Eur J Radiol; 2012 Sep; 81 Suppl 1():S6-9. PubMed ID: 23083604
[No Abstract] [Full Text] [Related]
19. MR spectroscopy of head and neck cancer.
Abdel Razek AA; Poptani H
Eur J Radiol; 2013 Jun; 82(6):982-9. PubMed ID: 23485098
[TBL] [Abstract][Full Text] [Related]
20. Characterisation of in vivo ovarian cancer models by quantitative 1H magnetic resonance spectroscopy and diffusion-weighted imaging.
Canese R; Pisanu ME; Mezzanzanica D; Ricci A; Paris L; Bagnoli M; Valeri B; Spada M; Venditti M; Cesolini A; Rodomonte A; Giannini M; Canevari S; Podo F; Iorio E
NMR Biomed; 2012 Apr; 25(4):632-42. PubMed ID: 22020805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
